Synonyms: ONO-7475 | ONO7475
Compound class:
Synthetic organic
Comment: We obtained the chemical structure for tamnorzatinib from the WHO's proposed INN list 127 (21 July 2022). In this document it was described as a tyrosine kinase inhibitor and antineoplastic. PubChem provided the synonym ONO-7475. ONO-7475 is a clinical stage inhibitor of the TAM family receptor tyrosine kinases AXL and MER, that has been developed as a drug for the treatment of leukaemia and advanced solid tumours [1,3].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[5-(6,7-dimethoxyquinolin-4-yl)oxypyridin-2-yl]-2,5-dioxo-1-phenyl-7,8-dihydro-6H-quinoline-3-carboxamide |
International Nonproprietary Names ![]() |
|
INN number | INN |
12167 | tamnorzatinib |
Synonyms ![]() |
ONO-7475 | ONO7475 |
Database Links ![]() |
|
CAS Registry No. | 1646839-59-9 (source: WHO INN record) |
GtoPdb PubChem SID | 472319213 |
PubChem CID | 90645873 |
Search Google for chemical match using the InChIKey | WHMMKPWGWNYYFE-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | WHMMKPWGWNYYFE |
Search PubMed clinical trials | tamnorzatinib |
Search PubMed titles | tamnorzatinib |
Search PubMed titles/abstracts | tamnorzatinib |
UniChem Compound Search for chemical match using the InChIKey | WHMMKPWGWNYYFE-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WHMMKPWGWNYYFE-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Tamnorzatinib (links to external site)
Cat. No. HY-114358 |